Please login to the form below
skin health
This page shows the latest skin health news and features for those working in and with pharma, biotech and healthcare.
Sanofi/ Regeneron’s Dupixent recommended by CHMP to treat eosinophilic oesophagitis
The EC’s decision was based on positive results from two phase 3 trials in which Dupixent demonstrated a significant improvement in itch, skin lesions and health-related quality of life
Latest news
-
Sanofi and Regeneron’s Dupixent granted EC approval for prurigo nodularis
Two phase 3 trials showed a reduction in itch, skin lesions and health-related quality of life. ... The EC’s decision is based on positive results from two phase 3 trials, PRIME and PRIME2, in which Dupixent demonstrated a significant improvement in
-
Sanofi/Regeneron’s Dupixent receives CHMP recommendation for prurigo nodularis
Two phase 3 trials showed a reduction in itch, skin lesions and health-related quality of life. ... The CHMP’s decision is based on positive results from two phase 3 trials, PRIME and PRIME2, in which Dupixent demonstrated a significant improvement in
-
Best practice in UK dermatology care celebrated at second national awards
Winner. Skin Cancer Teledermatology Assessment Service, Isle of Wight by The Lighthouse Clinic. ... Commended. Digitalising Dermatology Referrals by Leeds Teaching Hospitals. Finalists. Remote Dermatology: Picture the Future of Skin Health by DermView
-
Happify Health and Almirall launch Claro to support psoriasis patients
Italy. The digital wellness app has been developed through the innovative partnership of both global pharmaceutical companies specialising in skin health. ... Claro is the first iteration of Happify Health's platform for people with the skin condition
-
Almirall launches Actinic Keratosis Global Day during Skin Cancer Awareness Month
The global event will take place annually on 24 May to increase awareness of skin cancer. ... Almirall, a biopharma specialising in skin health, has unveiled the first Actinic Keratosis Global Day in partnership with Euromelanoma and AEDV Fundación Piel
More from news
Approximately 1 fully matching, plus 26 partially matching documents found.
Latest Intelligence
-
Creating strong commercial relationships in a COVID world
There are many potentially life-changing digital innovations on the market. For example, diabetes monitors that are applied to the skin and send patient health metrics remotely to a mobile app.
-
Galderma launches Rosacea awareness campaign
Campaign comes on the back of Rosacea Awareness Month. Galderma, Nestlé Skin Health’s medical solutions business, has launched a social media campaign to show the hidden impact of rosacea, a ... often under- prioritised disease area,” said Kamel
-
Deal Watch February 2017
There were six deals worth more than $1bn this month: three focused on medtech, two on ethical pharmaceuticals and one in nutrition/ consumer health. ... Licence with co-promotion option. 2, 057. Cynosure/ Hologic. Medical aesthetics portfolio inc
-
Pharma deals during April 2014
Consumer healthcare:. The joint GSK/ Novartis Consumer Healthcare business inherits a leading position in four key OTC categories - Wellness, Oral Health, Nutrition and Skin Health. ... April also saw Cardinal Health acquire the privately held device
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
If our patients are diverse, why are clinical trials so white?
How many times have you been told to put on sunscreen to prevent skin cancer? ... The society is committed to educating healthcare providers and the general public on dermatologic health issues related to skin of colour.
-
War on drugs: the use of controlled substances in medicine
Nixon’s war on drugs meant that all research into controlled substances’ efficacy on health conditions was halted. ... It has shown promise in mental health conditions, skin conditions and a cannabis-based medicine is now available on the NHS for the
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
-
Senior Medical Writer
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Manager
- Highly competitive salary
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- FDA external report recommends actions to address US opioid crisis
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- The increasing value of rare disease trials
- Wrapping up EAU with a Look at Medscape’s Urology Impact
- MHRA to introduce new UK clinical trials framework
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Congress is in session – how companies are boosting their impact and engagement
- AstraZeneca announces major expansion of Canadian research footprint
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
PMHub
Healthcare Media Europe – HME Ltd
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
